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Abstract Acute cellular rejection (ACR) compromises
graft function after heart transplantation (HTX). The pur-
pose of this study was to describe systolic myocardial
deformation in pediatric HTX and to determine whether it
is impaired during ACR. Eighteen combined cardiac
magnetic resonance imaging (CMR)/endomyocardial
biopsy (EMBx) examinations were performed in 14 HTX
patients (11 male, age 13.9 ± 4.7 years; 1.2 ± 1.3 years
after HTX). Biventricular function and left ventricular
(LV) circumferential strain, rotation, and torsion by
myocardial tagging CMR were compared to 11 controls as
well as between patients with and without clinically sig-
nificant ACR. HTX patients showed mildly reduced
biventricular systolic function when compared to controls
[LV ejection fraction (EF): 55 ± 8% vs. 61 ± 3, p = 0.02;
right ventricular (RV) EF: 48 ± 7% vs. 53 ± 6, p = 0.04].
Indexed LV mass was mildly increased in HTX patients
(67 ± 14 g/m2 vs. 55 ± 13, p = 0.03). LV myocardial
deformation indices were all significantly reduced,
expressed by global circumferential strain (-13.5 ± 2.3%
vs. -19.1 ± 1.1%, p\ 0.01), basal strain (-13.7 ± 3.0%
vs. -17.5 ± 2.4%, p\ 0.01), mid-ventricular strain
(-13.4 ± 2.7% vs. -19.3 ± 2.2%, p\ 0.01), apical strain
(-13.5 ± 2.8% vs. -19.9 ± 2.0%, p\ 0.01), basal rota-
tion (-2.0 ± 2.1 vs. -5.0 ± 2.0, p\ 0.01), and torsion
(6.1 ± 1.7 vs. 7.8 ± 1.1, p\ 0.01). EMBx demonstrated
ACR grade 0 R in 3 HTX cases, ACR grade 1 R in 11 HTX
cases and ACR grade 2 R in 4 HTX cases. When com-
paring clinically non-significant ACR (grades 0–1 R vs.
ACR 2 R), basal rotation, and apical rotation were worse in
ACR 2 R patients (-1.4 ± 1.8 vs. -4.2 ± 1.4, p = 0.01
and 10.2 ± 2.9 vs. 2.8 ± 1.9, p\ 0.01, respectively).
Pediatric HTX recipients demonstrate reduced biventricu-
lar systolic function and decreased myocardial contractil-
ity. Myocardial deformation indices by CMR may serve as
non-invasive markers of graft function and, perhaps,
rejection in pediatric HTX patients.
Keywords Acute cellular rejection  Pediatric  Heart
transplant  Myocardial deformation  Magnetic resonance
imaging
Introduction
Advances in donor and recipient selection, surgical tech-
niques, and medical management have substantially
improved survival of children after heart transplantation
(HTX) [1–3]. Despite these encouraging developments,
cardiovascular health remains compromised in many chil-
dren and adolescents after HTX. Acute cellular rejection
(ACR)—although its prevalence has decreased over the
years—remains an important cause of morbidity and graft
loss and is one of the factors compromising the long-term
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functional integrity of the graft [1–5]. Acute cellular
rejection is a risk factor for graft loss, cardiac dysfunction,
coronary vascular disease, and mortality. Therefore,
surveillance for ACR is crucial, especially since many
patients with ACR are asymptomatic [2, 6]. Presently,
endomyocardial biopsy (EMBx) is the gold standard to
detect subclinical ACR in HTX patients, as serologic and
echocardiographic markers are not sufficiently sensitive
and/or specific [1–6]. However, the radiation burden, the
invasive nature of the test, as well as the need for sedation
or general anaesthesia are barriers to EMBx, especially in
children [1–6]. Suitable alternative tests for ACR are
therefore desirable for pediatric HTX patients [2].
Abnormal left ventricular (LV) torsion and biventricular
systolic dysfunction have been reported in pediatric HTX
recipients [5, 7–11], and reduced LV ejection fraction (EF)
has been proposed as a non-invasive marker of ACR in
children [7]. However, little is known about LV myocardial
deformation after pediatric HTX in relationship with graft
rejection. Cardiac magnetic resonance imaging (CMR) is
the reference method for biventricular volumetry and EF,
and is also suited to assess LV strain, rotation, and torsion
[8, 12–19]. The purpose of this study was to assess, in




This is a single-center, prospective cross-sectional cohort
study. The study was approved by the institutional research
ethics board and informed consent was obtained from all
participants and/or their legal guardians at the time of
enrolment. All children and adolescents after HTX who
underwent a clinically indicated EMBx between April
2010 and March 2011 were invited to undergo a CMR scan
on the same day. EMBx were requested either as part of
routine ACR surveillance (17 EMBx) or as follow-up after
treatment of ACR (1 EMBx). None of the EMBx were
performed because of a suspicion of ACR. CMR exami-
nation was conducted immediately before the EMBx in all
participants, either in an awake cooperative patient or
under the same anaesthesia as the EMBx. Exclusion criteria
were general contraindications to undergo CMR, arrhyth-
mia interfering with CMR acquisition as well as poor CMR
image quality. Family members of patients with arrhyth-
mogenic right ventricular cardiomyopathy (ARVC) who
underwent CMR screening for the condition were recruited
as controls. Individuals with any signs or symptoms of
ARVC, including abnormal CMR findings, were excluded
from the control cohort. Patient charts were reviewed for
age of the organ donor, ischemia time of the donor heart,
bypass time at HTX, and immunosuppressive medications
at time of CMR/EMBx. Where available, the reports of
fluoroscopic angiography (within 1 year of CMR/EMBx)
were reviewed for signs of cardiac allograft vasculopathy
(CAV) in accordance with the International Society for
Heart and Lung Transplantation (ISHLT) grading system
[20]. At the authors’ institution, routine two-yearly
screening by coronary angiography for cardiac allograft
vasculopathy (CAV) begins between 2 and 5 years post-
HTX, depending on age, size, and risk factors for devel-
opment of CAV.
Cardiovascular Magnetic Resonance Imaging
CMR examinations were performed on a 1.5-T scanner
(‘Avanto’ Siemens Medical Solutions, Erlangen, Ger-
many). For ventricular volumetry, a short-axis cine stack
was acquired with a steady-state free precession technique,
using the following parameters: temporal resolution to
allow 20 phases per cardiac cycle, repetition time 2.97 ms,
echo time 1.34 ms, field of view 260 mm, flip angle 78,
voxel size 1.3 9 1.3 9 5 mm, and variable spacing to
cover both ventricles with 12–13 slices.
Myocardial tagging of the LV was obtained at three
levels in short axis (base, mid-ventricular, and apical).
Imaging parameters included a temporal resolution suffi-
cient to allow 14 or more true phases per cardiac cycle,
repetition time 11.7 ms, echo time 6.6 ms, flip angle 7,
voxel size 2.4 9 1.6 9 5 mm, and grid size 6 mm.
Biventricular end-diastolic volume (EDV), end-systolic
volume (ESV), and EF, as well as LV mass were analyzed
in the usual fashion [21], using commercially available
software (‘QMass’ version 7.2; Medis, Leiden, The
Netherlands). Indexation to body surface area (BSA) was
performed using the Mosteller formula (BSA = [H 9 W/
3600]), where H is the height in centimeters, and W is the
weight in kilograms. LV mass was also indexed for LV
EDV, to allow for comparison of LV mass relative to LV
size.
The analysis of CMR tagging images was performed by
a single observer with 10 years of experience in CMR, who
was blinded towards the patients’ clinical status, and the
results of the endomyocardial biopsies. The images were
analyzed using ‘HARP’ software (Diagnosoft, Palo Alto,
California, USA) [14, 16]. Transmural circumferential
Lagrangian strain and rotation were measured at the basal,
mid-ventricular, and apical levels of the LV, as was
described elsewhere [14, 16]. In brief, strain is defined as
the relative deformation of myocardium, with negative
values denoting shortening [8, 12]. Rotation is defined as
the angular change of the LV in a short-axis plane about the
LV long axis [12]. For this, epicardial and endocardial
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contours at all 3 levels were traced in mid-systole [14, 16].
An automated contour detection algorithm detected the
contours in the remaining phases of the cardiac cycle. The
myocardium on each short-axis circumference was divided
into 24 segments (Fig. 1) [14, 16]. Non-tracking segments
were excluded from analysis [14]. By convention, the
assessment of LV strain and rotation was considered fea-
sible when the myocardial borders were auto-tracked
correctly in 13 or more of the 24 segments. Peak strain and
rotation were obtained as the differences between the first
and the last systolic image, with end-systole defined as the
phase with the smallest LV cross-sectional area at the mid-
ventricular level [14, 16]. Circumferential strain was cal-
culated per slice as the average of all included segments
[14, 16]. Global circumferential strain was calculated as the
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Fig. 1 a–d Left ventricular
(LV) ejection fraction, right
ventricular ejection fraction, LV
mass, and LV mass-to-volume
ratio in controls and transplant
recipients. LV ejection (a) and
right ventricular (RV) ejection
fraction (b) are significantly
lower in heart transplant
patients, but show strong
overlap between healthy
controls and heart transplant
patients. Indexed LV mass
(c) and LV mass-to-end-
diastolic volume (EDV) ratio
(d) were also significantly
increased in transplant patients
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levels [14, 16]. All results on circumferential strain will be
referred to a ‘strain’ from here on. Rotation was calculated
per slice in a similar way to that described for the strain
assessment, but only for the LV apex and base [14, 16–19].
Clockwise rotation as viewed from the apex was expressed
as a negative angle [17–19]. LV twist was calculated as the
net difference between LV apical and basal rotation
[12, 17–19]. As the intersubject comparability of twist is
limited in the pediatric population due to considerable
interindividual variations in heart length and diameter,
torsion is preferred to twist as it corrects for cardiac size
[19]. Torsion was calculated as follows [17–19]: (apical
rotation - basal rotation) 9 (apical radius ? basal radius)/
(2 9 distance between apex and base). The distance
between the apical and basal slices was derived from short-
axis stack as the distance between the two slice locations.
The radii of base and apex were calculated as the average
of 3 cross-sectional diameters of the tagging contours in the
end-systolic phase, divided by 2.
Endomyocardial Biopsy
Cardiac catheterization for EMBx was performed using a
right internal jugular venous approach. Four to five endo-
cardial samples were taken from the right ventricular (RV)
aspect of the interventricular septum. Experienced cardiac
pathologists, who were blinded towards the imaging find-
ings and the patients’ clinical status, performed the histo-
logical analysis of the specimens. Biopsies were clinically
graded according to the 2005 nomenclature of the ISHLT
for ACR as 0, 1 R, 2 R, or 3 R [22] and antibody-mediated
rejection (AMR) as AMR 0, AMR 1 [23].
Statistical Analysis
Analyses were done in both a SPSS software package
(version 20, Chicago, Illinois, USA) and R 3.1.2 [24]. All
data are presented as mean ± standard deviation, unless
stated otherwise. Independent samples T test was used to
express differences between patients and control subjects.
Correlation between variables was assessed using Pear-
son’s correlation coefficient. Statistical significance was
indicated by p\ 0.05.
Results
Fourteen pediatric HTX recipients (11 male, 3 female) and
11 controls (4 male, 7 female) participated in the study.
Donor age was 15.1 ± 9.3 years (8 days to 29 years).
Ischemic time and bypass time at HTX had been
209 ± 73 min and 121 ± 59 min, respectively. Immune
suppression consisted of Tacrolimus and mycophenolate
mofetil in 13 HTX patients, supplemented by Sirolimus in
one and prednisone in another HTX patient. In addition, 11
HTX patients received statins and 10 HTX patients
received antihypertensive medication. Two patients were
studied on more than one occasion: one patient underwent
two CMR/EMBx investigations (5 months apart) and
another patient had 4 combined CMR/EMBx investigations
(intervals of 1, 4, and 7 months, respectively). Coronary
angiography was performed in 9 of 14 patients, showing no
evidence of CAV (all showed CAV 0).
A total of 18 combined CMR/EMBx investigations were
analyzed and results are summarized in Table 1. General
anaesthesia was performed in three combined CMR/EMBx
procedures. In the other 15 CMR/EMBx procedures,
patients were awake during the CMR and received sedation
for the EMBx. Six patients underwent early EMBx after
HTX (within 6 months) with an interval between HTX and
EMBx between 12 days and 24 weeks. Acute cellular
rejection grade 0 R was observed in three cases, ACR grade
1 R in 11 cases and ACR grade 2 R in 4 cases. No case of
ACR grade 3 R was detected. The HTX patient with 2
CMR/EMBx investigations showed ACR grade 1 R on
both occasions. The HTX patient with 4 repeated investi-
gations demonstrated ACR grade 1 R on the first 2 EMBx
and ACR grade 2 R on the last 2 EMBx. Antibody-medi-
ated rejection was not observed in this study.
The 18 CMR studies demonstrated mildly reduced left
and right ventricular EFs in HTX patients when compared
to controls (p = 0.02 and p = 0.04, respectively) (Table 1;
Fig. 1). Patients after HTX also showed decreased global
circumferential strain, strain at all three LV short-axis
levels, basal rotation, and LV torsion when compared with
controls (p\ 0.01 for all) (Table 1; Fig. 2). Seven HTX
patients had LV EF\55% (range 31–54%) and four HTX
patients had RV EF\45% (range 34–44%). No differences
in biventricular dimensions (indexed EDV and ESV) were
observed between patients and controls. HTX patients
showed increased indexed LV mass when compared to
controls (p = 0.03) (Fig. 1c), also when LV mass was
corrected for LV EDV (p = 0.03) (Table 1; Fig. 1d).
Increased LV mass correlated with apical strain
(R = 0.53, p = 0.03), while LV mass/EDV correlated with
global strain (R = 0.57, p = 0.01) (Fig. 3), mid-ventricu-
lar strain (R = 0.55, p = 0.02), and apical strain
(R = 0.61, p\ 0.01). Reduced LV torsion correlated with
basal strain (R = 0.58, p = 0.01) and apical rotation
(R = 0.66, p\ 0.01). Myocardial deformation and biven-
tricular EFs were not associated with ischemic time and
bypass time at HTX in our study.
When HTX patients were stratified by early (\6 months,
6 CMR/EMBx studies) versus late (C6 months, 12 studies)
CMR/EMBx after HTX, strain at mid-ventricular and
apical levels were better in the ‘late’ group (-11.7 ± 2.1
Pediatr Cardiol (2017) 38:1198–1205 1201
123
vs. -14.5 ± 2.5, p = 0.02 and -11.8 ± 2.6 vs.
-14.5 ± 2.5, p = 0.02, respectively). Late and early time
points after HTX did not differ with regards to rotation,
torsion, ventricular volumes, LV mass, and ejection frac-
tions. When comparing only patients without significant
rejection (ACR 0 or 1 R), mid-ventricular and apical strain
were no longer statistically different between early and late
after transplant, although a trend prevailed (p = 0.06 for
both).
Patients with clinically non-significant ACR (grades 0–1
R) were compared with HTX patients with more significant
ACR (grade 2 R), showing that basal rotation and apical
rotation were worse in patients with ACR 2R (-1.4 ± 1.8
vs. -4.2 ± 1.4, p = 0.01 and 10.2 ± 2.9 vs. 2.8 ± 1.9,
p\ 0.01, respectively), but not for biventricular dimen-
sions and ejection fractions, and the other myocardial
deformation indices. When comparing only the 14 first
CMR studies between patients with non-significant ACR
and those with significant ACR, basal and apical rotation
remained worse in patients with ACR 2 R (p\ 0.01 and
p\ 0.01, respectively).
Discussion
Abnormal myocardial deformation and systolic dysfunc-
tion have been reported in pediatric HTX recipients.
However, the extent of systolic dysfunction and myocardial
deformation abnormalities after pediatric HTX in rela-
tionship with graft rejection is unknown. The current CMR
study compares ventricular systolic function and myocar-
dial deformation between HTX patients and controls, and
describes their relationship with the presence of rejection
as determined by endomyocardial biopsy in pediatric HTX
recipients. The study adds the following to our under-
standing of cardiovascular health in pediatric patients after
HTX:
(a) Children after HTX have decreased biventricular
systolic function;
(b) They show evidence of decreased myocardial con-
tractility as evidenced by abnormal circumferential
strain, rotation, and torsion; and
(c) LV rotation is reduced with increased severity of
ACR.
Table 1 Demographics and
magnetic resonance results in
transplant recipients and
controls
HTX patients (n = 18) Controls (n = 11) p value





Interval HTX to CMR (years) 1.2 (1.3)
(12 days–5.0 years)
Height at CMR (cm) 155 (27) 156 (15) 0.94
Weight at CMR (kg) 64.0 (30.6) 49.1 (11.0) 0.13
Body surface area at CMR (m2) 1.61 (0.52) 1.45 (0.22) 0.33
Rejection grade 1 R 11
Rejection grade 2 R 4
LV EF (%) 55 (8) 61 (3) 0.02
LV EDV (ml/m2) 90 (23) 88 (14) 0.82
LV ESV (ml/m2) 42 (20) 35 (7) 0.25
LV mass (g/m2) 67 (14) 55 (13) 0.03
LV mass/LV EDV (g/ml) 0.78 (0.21) 0.62 (0.12) 0.03
RVEF (%) 48 (7) 53 (6) 0.04
RV EDV (ml/m2) 104 (22) 97 (12) 0.30
RV ESV (ml/m2) 54 (15) 45 (9) 0.10
Global strain (%) -13.5 (2.3) -19.1 (1.1) \0.01
Strain base (%) -13.7 (3.0) -17.5 (2.4) \0.01
Strain mid-ventricular (%) -13.4 (2.7) -19.3 (2.2) \0.01
Strain apex (%) -13.5 (2.8) -19.9 (2.0) \0.01
Rotation base () -2.0 (2.1) -5.0 (2.0) \0.01
Rotation apex () 8.6 (4.1) 8.3 (3.0) 0.84
LV torsion () 6.1 (1.7) 7.8 (1.1) \0.01
Results are expressed as mean values and standard deviations between brackets
CMR cardiac magnetic resonance, EDV end-diastolic volume, EF ejection fraction, ESV end-systolic
volume, HTX heart transplant, LV left ventricle, RV right ventricle
1202 Pediatr Cardiol (2017) 38:1198–1205
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Ventricular Ejection Fraction and LV Mass
On average, LV and RV EFs were mildly reduced in HTX
recipients compared to controls, although most children’s
EFs remained within the normal range. The etiology of the
reduced global ventricular systolic function is unclear:
transient organ ischemia during transplantation, reperfu-
sion injury, cardiotoxic medications, CAV, and ACR have
all been named as possible contributors to impaired ven-
tricular function [1–5]. Studies investigating the suitability
of LV EF as a marker of ACR have yielded mixed results
in adults and children [2, 5, 6, 25, 26]. In the present study,
LV and RV EF did not distinguish between clinically
significant and no ACR [2, 5, 6, 26]. Patients had larger LV
mass and increased mass-to-volume ratio, the latter sug-
gesting that the increased LV mass is not merely the result
of larger graft organs and a donor-recipient mismatch.
Another possibility is that the increased LV ‘mass’ by
CMR is a reflection of edema, rather than myocyte
hypertrophy [1–5, 27]. However, cases with ACR 2R at the
time of CMR did not have higher LV mass or mass-to-
volume ratio as compared to controls.
Circumferential Strain, Rotation, and Torsion
Not only global ventricular function is decreased in HTX
recipients, myocardial deformation as expressed by
abnormal circumferential strain, rotation, and torsion is
also impaired: we found reduced global circumferential
strain as well as strain at all three LV short-axis levels,
corroborating previous reports [1, 3–5, 26]. Myocardial
strain has been proposed as a sensitive marker of subclin-
ical changes in myocardial performance in a variety of
conditions; abnormalities in strain often precede a decline
in EF [27, 28]. Miller and colleagues witnessed an asso-
ciation of reduced circumferential strain by CMR tagging
in adult HTX recipients with clinically significant ACR
(grade 2 R or higher) [26]. The mid-ventricular circum-
ferential strain values that they report are comparable to
those that we found in our pediatric cohort. In their study, a
reduction of mid-ventricular strain was associated with
CMR markers of myocardial edema including myocardial
T1 and T2 relaxation times, suggesting myocardial edema
due to inflammation as a possible cause of functional
demise [26]. In a rodent transplant model, areas of abnor-
mal circumferential strain by CMR tagging corresponded
to regions of macrophage infiltration [29]. In the present
study, we did not measure CMR markers of myocardial
edema, but did not find differences in strain with ACR 2 R
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Fig. 2 Torsion in controls and transplant recipients. Acute cellular
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Fig. 3 Left ventricular mass-to-end-diastolic volume ratio versus
global strain in transplant patients and controls. LV mass-to-end-
diastolic volume (EDV) ratio versus global strain in transplant
patients (filled circle) and controls (filled square)
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Controversy persists over which strain dimension is
primarily decreased after HTX and affected the most dur-
ing ACR. In contrast to our and Miller’s studies which
focused on circumferential strain [26], several echocar-
diography-based reports—using speckle-tracking and tis-
sue Doppler imaging—described predominantly reduced
longitudinal LV strain and relatively preserved circumfer-
ential LV strain after pediatric and adult HTX
[8, 9, 28, 30, 31]. Other studies in adults—both by
echocardiography and CMR tagging—found longitudinal
and circumferential strain to be equally affected by clini-
cally significant ACR ([grade 2 R) [6, 25, 26, 31]. Apart
from ACR, it is possible that other factors impact
myocardial mechanics. Some of these factors are related to
the transplant surgery, although myocardial deformation
and biventricular EF were not associated with ischemic and
bypass times at HTX in our study. In clinical practice,
patients often experience some degree of cardiac dys-
function early after transplantation; most regain normal
systolic function after several weeks to months. In agree-
ment with this clinical observation, patients who underwent
CMR within the first 6 months after HTX showed lower
mid-ventricular and apical circumferential strain, indicat-
ing decreased contractility early after transplantation.
Whether this improvement in contractility reflects favor-
able myocardial remodeling or is primarily reflective of the
higher incidence of rejection early after HTX remains to be
studied.
Torsion describes the wringing motion of the LV cavity
secondary to rotation at the base and at the apex in opposite
directions. In comparison with rotation, torsion is a more
comprehensive parameter of the LV’s twisting motion as it
represents the spiral orientation of LV fibers, incorporating
both basal and apical rotation [8, 10, 11]. It has an
important role for both systolic and diastolic function:
ejection during systole is assisted by rotational deforma-
tion, whereas rapid untwisting during early diastole
enhances LV suction by augmenting intraventricular pres-
sure gradients allowing for ventricular filling at a relatively
low left atrial filling pressure [9]. Donofrio et al. were the
first to report reduced torsion in pediatric HTX recipients
by use of CMR [8]. Similarly, the current study revealed
reduced LV torsion, mostly due to reduced rotation at the
base. The etiology of abnormal torsion and why apical
rotation appears to be relatively preserved, is ultimately
unclear. Incomplete or heterogeneous cardiac re-innerva-
tion after cardiac denervation of the transplanted heart,
rejection, and allograft vasculopathy have all been pro-
posed as factors in decreased rotation [8–11].
Donofrio et al. did not relate rotation and torsion to the
presence of ACR [8]. In the cohort studied here, LV basal
and apical rotation were reduced with increasing degree of
ACR, corroborating reports in adults which have described
links between rotation and ACR, using both echocardiog-
raphy and CMR [7, 8, 11, 32]. Sato et al. found that
reduced torsion by echocardiography of at least 25% as
compared to a patient’s baseline predicted biopsy-proven
ACR C 2R ISHLT in adult HTX recipients [32]. In their
study, LV torsion returned to baseline within an average of
nine days after immunosuppression was augmented.
Limitations
The principal limitation of this study is—as discussed—
the small sample size, particularly the group of HTX
patients with grade 2 R ACR, which limits the general-
izability of the results. Two patients were studied on more
than one occasion which may have influenced the com-
parison between patients between controls and HTX and
between those with significant ACR and those with ACR
0/1 R. However, most of the differences between patients
and controls persisted when only one CMR per patient
was analyzed. In summary, the observations in this study
are hypothesis-generating and must be substantiated in
larger studies. Furthermore, while EMBx is the gold
standard for the diagnosis of rejection, it may not be
reflective of the LV myocardium. This principal short-
coming of EMBx for rejection surveillance may have
obscured further associations between CMR markers and
rejection.
Conclusions
Pediatric HTX recipients have mildly reduced biventricular
systolic function and abnormal myocardial deformation
indices, expressed by impaired LV circumferential strain,
rotation, and torsion. These indices may serve as markers
of graft function in pediatric HTX patients. Left ventricular
rotation is reduced with increased severity of ACR. Studies
in larger populations are necessary to clarify whether CMR
metrics of myocardial contractility can be used to screen
for ACR.
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